BACKGROUND
International recommendations advise against the use of intravenous rehydration therapy in children with severe acute malnutrition because of the con...
BACKGROUND
The management of post-meningitis sequelae is a priority in the WHO Roadmap to Defeat Meningitis by 2030. Nonetheless, the prevalence of sequelae in ...
BACKGROUND
The global epidemic of Mycoplasma genitalium (MG) is marked by its widespread prevalence, varied resistance patterns, and significant impact on sexua...
OBJECTIVES
Cholera is an easily treatable disease, but many people are still unnecessarily dying from it. To improve current case management practices and preve...
In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...
BACKGROUND
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...
INTRODUCCIÓN
El dengue es una enfermedad febril que afecta a la región de las Américas. En Honduras, en los últimos cinco a...
INTRODUCCIÓN
La Organización Mundial de la Salud (OMS) estima que aproximadamente el 5% de la población adulta de América Latina sufre algún grado de depresión ...
BACKGROUND
Improving treatment success rates among multi drug-resistant tuberculosis (MDR-TB) patients is critical to reducing its incidence and mortality, but adherence poses a...
Video-enabled directly observed therapy (video-DOT) has been proposed as an additional option for treatment provision besides in-person DOT for patients with drug-resistan...
The 2014 West Africa Ebola outbreak underlined inadequacies of current personal protective equipment (PPE), such as being uncomfortable and hot, causing excessive sweati...
The risk of cholera outbreaks spreading rapidly and extensively is substantial. Case-area targeted interventions (CATI) are based on the premise that early detection can...
INTRODUCTION
Hepatitis E causes high mortality among pregnant women, with case fatality risks over 30% and adverse fetal outcomes. There is an evidence gap on the safety of the ...